NANOBIOTIX SA - ADR (NBTX)

US63009J1079 - ADR

6.07  +0.34 (+5.93%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
50K
-26.47%		10K
-80.00%		34.17M
EBITDA
YoY % growth
-34.674M
22.97%		-51.019M
-47.14%		-45.202M
11.40%		-15.759M
65.14%		N/AN/AN/A
EBIT
YoY % growth
-36.428M
22.13%		-52.579M
-44.34%		-46.702M
11.18%		-16.575M
64.51%
Operating Margin
-72,856.00%-525,790.00%N/A-48.51%
EPS
YoY % growth
-1.04
40.43%		-1.00
3.57%		N/A-0.52

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q2 / 24 Q4 / 24
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -0.59
-5.26%		-0.55-0.05-8.93%
Q2 2022
Q2Q % growth		 -0.57
13.64%		-0.53-0.03-6.44%
Q4 2021
Q2Q % growth		 -0.35
4.08%		-0.530.1834.17%
Q2 2021
Q2Q % growth		 -0.65
3.30%		-0.49-0.16-32.73%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 2.866M-2.866M-100.00%
Q2 2022
Q2Q % growth
-100.00%		1.02M-1.02M-100.00%
Q4 2021
Q2Q % growth
-100.00%		1.02M-1.02M-100.00%
Q2 2021
Q2Q % growth		 10K
-75.00%		1.071M-1.061M-99.07%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0.22%
RevenueN/A N/A 0% -8.84%